MetaCap

Microbot Medical Inc. (MBOT)

NASDAQ: MBOTHealth CareMedical/Dental InstrumentsUSD

0.68-0.0633 (-8.52%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

MBOT stock chart

Technical analysis

Key statistics

All statistics
Market cap
$45.67M
EPS (TTM)
-$0.27
52-week range
0.52 – 2.86
Day range
0.6601 – 0.75
Volume / Avg
1.72M / 922.53K
Beta
—

52-week range

$0.52$2.86

MBOT stock today

Microbot Medical (MBOT) closed at $0.68 on Nov 20, down 8.52% (-$0.0633), versus the S&P 500's 3.70% decline. At this level, MBOT sits near the bottom of its 52-week range of $0.52 to $2.86: 76.2% below the high, set on Mar 11, 2026 and 30.8% above the low. MBOT is down 66.0% year to date, underperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has lost 62.8%.

Microbot Medical has posted a net loss over the last twelve months (EPS of -$0.27), so its P/E ratio is not meaningful.

Summary generated from market data by MetaCap's automated system. Methodology

About Microbot Medical

Company profile

Microbot Medical Inc. is a medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY, an endovascular robotic surgical system designed to maneuver guidewires and over-the-wire devices such as microcatheters within the body's vasculature for use in cardiovascular, peripheral, endovascular, and neurovascular operations.

Industry
Medical/Dental Instruments
CEO
Mr. Harel Gadot
Headquarters
Hingham, MA
Employees
43

Financial highlights

Full financials

Microbot Medical reported a net loss of $13.1 million, compared with a loss of $11.4 million a year earlier. Diluted earnings per share came in at -$0.29.

Microbot Medical annual revenue, net income and EPS
Fiscal yearFY 2025FY 2024FY 2023FY 2022FY 2021
Revenue—————
Growth—————
Net income$-13.14M$-11.44M$-10.74M$-13.17M$-11.31M
EPS (diluted)$-0.29$-0.73$-1.05$-1.81$-1.59

Analyst forecast

Forecast

Consensus (3 analysts)

strong_buy

Avg. price target

$6.33+830.88%

  • Strong buy 0
  • Buy 3
  • Hold 0
  • Sell 0
  • Strong sell 0

Target range

Low $3.00High $12.00

Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.

Earnings

Earnings history
Last reported (Sep/2026)
Nov 13, 2026
EPS actual vs est.
$-0.09 vs $-0.08
Surprise
-12.50%

MBOT news

All MBOT news

Microbot Medical peers

Health Care sector
MBOT peer companies
CompanyPrice% ChgMarket capCompare
DXRDaxor Corporation7.45-7.33%$43.49Mvs MBOT
SRTSSensus Healthcare Inc.2.26-4.24%$37.20Mvs MBOT
LNSRLENSAR Inc.4.46-3.88%$54.83Mvs MBOT
MDAISpectral AI Inc. Class A1.04-20.61%$33.47Mvs MBOT
TELATELA Bio Inc.0.6885-5.27%$31.11Mvs MBOT
XTNTXtant Medical Holdings Inc.0.21-2.82%$29.49Mvs MBOT
NSPRInspireMD Inc.0.54-12.97%$29.23Mvs MBOT
NEPHNephros Inc.2.61-8.10%$28.37Mvs MBOT

Indexes, lists and sector

Microbot Medical stock FAQ

What is Microbot Medical's stock price today?

MBOT last traded at $0.68 as of Nov 20, 4:00 PM EST, down 8.52% on the day. Prices are delayed at least 15 minutes.

Does Microbot Medical pay a dividend?

No. Microbot Medical does not currently pay a regular cash dividend.

Who is Microbot Medical's CEO?

Mr. Harel Gadot is the chief executive officer of Microbot Medical Inc., which has about 43 employees.

Has MBOT ever split its stock?

Yes. The most recent MBOT stock split was a 1-for-15 split on Sep 5, 2018, one of 4 splits on record.

What is the MBOT 52-week high?

The 52-week high for MBOT is $2.86 and the 52-week low is $0.52. The stock is currently 76.2% below its high.

Compare MBOT